# Evaluating Cancer Drugs in Patients with Central Nervous System Metastases:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/evaluating-cancer-drugs-in-patients-with-central-nervous-system-metastases-guidance-for-industry/cd630104-b6ee-4993-a2ff-85effca3e866

> FDA guidance document: Evaluating Cancer Drugs in Patients with Central Nervous System Metastases:  Guidance for Industry. Issue date: July 01, 2021. Get complete insights and analysis.

---

## Details

- Title: Evaluating Cancer Drugs in Patients with Central Nervous System Metastases:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Office of the Commissioner
- Office URL: /offices/office-of-the-commissioner/79483979-9582-427f-ac3d-46c715811424
- Issue Date: 2021-07-01
- Comment Close Date: 2020-10-26
- Last Changed: 2021-07-03
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2020-D-0938">FDA-2020-D-0938</a>

## Related Documents

- [Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-trial-endpoints-for-the-approval-of-cancer-drugs-and-biologics-guidance-for-industry/2ab76b05-d847-445c-b212-0047a592f760)
- [Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products](https://www.globalkeysolutions.net/guidances/guidance-document/adjusting-for-covariates-in-randomized-clinical-trials-for-drugs-and-biological-products/f58b2adc-b92a-4458-b269-5346d25a8a39)
- [Premenopausal Women with Breast Cancer: Developing Drugs for Treatment:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/premenopausal-women-with-breast-cancer-developing-drugs-for-treatment-guidance-for-industry/03f0e242-74ab-4a8e-b4b3-5d5c1d720852)